AUA/SUO guideline amendment (Part II) updates recommendations on evaluating and managing metastatic castration-resistant prostate cancer, after a literature review identifying 38 studies (2022–2025); guidance on non-metastatic CRPC was deemed current.
Guidelinen = 38 studies
Scarpato et al. Advanced Prostate Cancer: AUA/SUO Guideline Amendment (2026) Part II: Evaluation and Management of Metastatic Castration-Resistant Prostate Cancer